Researcher
Jeroen Dekervel
- Disciplines:Analysis of next-generation sequence data, Single-cell data analysis, Cancer diagnosis, Cancer therapy
Affiliations
- Digestive Oncology (Division)
Member
From1 Aug 2022 → Today - Clinical Digestive Oncology (Division)
Member
From1 Oct 2018 → Today - Hepatology (Division)
Member
From1 Oct 2012 → 2 Oct 2016
Projects
1 - 7 of 7
- Neoadjuvant therapy in the treatment of esophageal adenocarcinoma: one size doesn’t fit allFrom14 Nov 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Multicenter validation trial of [18F]AlF-FAPI-74 for PET imaging of cancer-associated fibroblasts through fibroblast activation protein inhibitors (FAPI) in digestive tumorsFrom1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Validation, refinement and spatial orientation of CD45RA effector-memory CD8 T-cells and PDL1- expressing CXCL10+ macrophages as predictive markers for response to immune checkpoint inhibition in advanced hepatocellular carcinoma.From1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- [18F]AlF-NOTA-octreotide PET imaging of the somatostatin receptor in neuroendocrine tumors: comparison with [68Ga]Ga-DOTATATE and evaluation of routine clinical use.From3 Oct 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Personalized multimodal treatment for resectable esophageal cancer by detecting minimal residual disease (MRD) using circulating tumor DNA (ctDNA):From11 Jan 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- SAFIR-ABC10: molecular screening for precision medicine in advanced biliary cancersFrom1 Jan 2022 → TodayFunding: Foundations, funds and other with scientific goal
- The search for biomarkers in systemic treatment of advanced hepatocellular carcinoma.From1 Oct 2019 → 1 Oct 2023Funding: FWO Strategic Basic Research Grant
Publications
31 - 40 of 58
- Cancer Surveillance in Healthy Carriers of Germline Pathogenic Variants inBRCA1/2: A Review of Secondary Prevention Guidelines(2020)
Authors: Sileny Han, Els Van Nieuwenhuysen, Toon Van Gorp, Chantal Van Ongeval, Jeroen Dekervel, Wouter Everaerts, Hans Wildiers, Ines Nevelsteen, Patrick Neven, Dirk Timmerman, et al.
- Gemcitabine Recruits M2-Type Tumor-Associated Macrophages into the Stroma of Pancreatic Cancer(2020)
Authors: Jeroen Dekervel, David Nittner, Louis Libbrecht, Stéphane Plaisance, Baki Topal, An Coosemans, Diether Lambrechts, Eric Van Cutsem, Chris Verslype, Jos van Pelt
- DNA methylation-driven EMT is a common mechanism of resistance to various therapeutic agents in cancer(2020)
Authors: Eva Galle, Bernard Thienpont, Sarah Cappuyns, Tom Venken, Pieter Busschaert, Matthias Van Haele, Tania Roskams, Jos van Pelt, Chris Verslype, Jeroen Dekervel, et al.
- Influence of pretreatment with everolimus or sunitinib on the subacute hematotoxicity of Lu-177-DOTATATE PRRT(2020)
Authors: Chris Verslype, Eric Van Cutsem, Jeroen Dekervel, Paul Clement, Kristiaan Nackaerts, Annouschka Laenen, Karolien Goffin, Koen Van Laere, Christophe Deroose
Pages: 644 - 651 - Anti-Cancer Activity of Acriflavine as Metabolic Inhibitor of OXPHOS in Pancreas Cancer Xenografts(2020)
Authors: Jeroen Dekervel, David Nittner, Eric Van Cutsem, Chris Verslype, Jos van Pelt
Pages: 6907 - 6916 - Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer(2019)
Authors: Eric Van Cutsem, Jeroen Dekervel
Pages: 1632 - 1643 - Extended criteria for liver transplantation in hepatocellular carcinoma. A retrospective, multicentric validation study in Belgium.(2019)
Authors: Jeroen Dekervel, Jacques Pirenne, Chris Verslype
Pages: 231 - 238 - Al18F-NOTA-octreotide: first comparison with 68Ga-DOTATATE in a neuroendocrine tumour patient(2019)
Authors: Elin Pauwels, Frederik Cleeren, Michel Koole, Jeroen Dekervel, Eric Van Cutsem, Chris Verslype, Koen Van Laere, Guy Bormans, Christophe Deroose
Pages: 2398 - 2399 - Gemcitabine induces Epithelial-to-Mesenchymal Transition in patient-derived pancreatic ductal adenocarcinoma xenografts(2019)
Authors: Ashenafi Shiferaw Bulle, Jeroen Dekervel, Louis Libbrecht, David Nittner, Eric Van Cutsem, Chris Verslype, Jos van Pelt
Pages: 765 - 779 - Relevance of the stroma in pancreatic ductal adenocarcinoma and its challenges for translational research(2017)
Authors: Ashenafi Shiferaw Bulle, Jeroen Dekervel, Schalk Van der Merwe, Eric Van Cutsem, Chris Verslype
Pages: 1 - 15